Filing Flows

Filing Flows › Companies › NutriBand › Cash flow

NutriBand cash flow, quarter by quarter

Latest: Q2 FY27 · from the cash-flow statements filed with the SEC

Free cash flow−$585K in Q2 FY27 · −$3.6M over twelve months

Operating cash flow−$585K
Free cash flow−$585K
Cash conversion cycle-176 days

Analysis

In Q2 FY27, NutriBand generated −$585K of operating cash flow. That is $728K more than in Q2 FY26 (−$1.3M).

Over the twelve months to Jul 31, 2026, operating cash flow was −$3.6M; the largest uses were operating cash flow ($3.6M), net borrowing (+) / repaid (−) ($15K); besides operations, cash came from other financing ($74K); the cash balance fell by $3.6M.

Operating cash flow was −$585K against net income of −$881K. The largest differences: deferred revenue +$70K, inventory −$49K, prepaid and other assets +$43K.

Its cash conversion cycle was -176 days (receivables 3 + inventory 53 − payables 231): suppliers fund its working capital.

Free cash flow

NutriBand: free cash flow by quarterNutriBand: free cash flow by quarter−$1.1MQ3 FY25−$1.2MQ4 FY25−$1.3MQ1 FY26−$1.3MQ2 FY26−$1.8MQ3 FY26−$732KQ4 FY26−$563KQ1 FY27−$585KQ2 FY27
Operating cash flow less capital spending.
NutriBand: operating cash flow against capital spendingNutriBand: operating cash flow against capital spendingOperating cash flowCapital spending−$1.0M$47KQ3 FY25−$1.2M$0Q4 FY25−$1.3M$5KQ1 FY26−$1.3M$0Q2 FY26−$1.8M$0Q3 FY26−$732K$0Q4 FY26−$563K$0Q1 FY27−$585K$0Q2 FY27
Latest (Q2 FY27): Operating cash flow −$585K, Capital spending $0.

Capital allocation, year by year

NutriBand: where the cash came from (up) and went (down), by fiscal yearNutriBand: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY22: Operating cash flow −$2.8MFY22: Net borrowing $265KFY22: Shares issued $583KFY22: Capital spending −$82K$848KFY22FY23: Operating cash flow −$3.0MFY23: Net borrowing −$18KFY23: Capital spending −$79KFY23FY24: Operating cash flow −$3.5MFY24: Net borrowing $87KFY24: Capital spending −$52K$87KFY24FY25: Operating cash flow −$4.6MFY25: Net borrowing −$21KFY25: Shares issued $8.4MFY25: Capital spending −$92K$8.4MFY25FY26: Operating cash flow −$5.1MFY26: Net borrowing −$22KFY26: Shares issued $5.4MFY26: Capital spending −$5K$5.4MFY26
Over these 5 years operating cash flow totalled −$19.1M; the largest uses were operating cash flow ($19.1M) and capital spending ($310K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$3.4M
Debtnone
Net cash$3.4M
Cash runway11 months

NutriBand is burning cash: its operations consume cash, a free cash flow of −$3.6M a year at the current rate against $3.4M of cash and investments: a runway of about 11 months before any new financing.

Where the cash came from and went

NutriBand: sources (+) and uses (−) of cash, Q2 FY27NutriBand: sources (+) and uses (−) of cash, Q2 FY27Operating cash flow−$585KCash drawn (+) / kept (−)$585KNet borrowing (+) / repaid (−)$1KOther financing−$1K
NutriBand: sources (+) and uses (−) of cash, TTM to Q2 FY27NutriBand: sources (+) and uses (−) of cash, TTM to Q2 FY27Operating cash flow−$3.6MCash drawn (+) / kept (−)$3.6MOther financing$74KNet borrowing (+) / repaid (−)−$15K

From profit to cash

NutriBand: net income to operating cash flow, Q2 FY27NutriBand: net income to operating cash flow, Q2 FY27Net income−$881KDepreciation & amortization$33KReceivables−$21KInventory−$49KPayables$5KDeferred revenue$70KPrepaid and other assets$43KOperating cash flow−$585K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 FY27353231-176
Q1 FY271245215-157
Q4 FY263137163-95
Q3 FY264145331-245
Q2 FY261935209-155
Q1 FY261146152-95
Q4 FY251349205-143
Q3 FY251340169-117

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 FY27−$585K—$1K—$585K−$585K
Q1 FY27−$563K—−$6K—$569K−$563K
Q4 FY26−$732K—−$5K—$737K−$732K
Q3 FY26−$1.8M—−$5K$75K$1.7M−$1.8M
Q2 FY26−$1.3M—−$5K—−$4.0M−$1.3M
Q1 FY26−$1.3M−$5K−$5K—$1.3M−$1.3M
Q4 FY25−$1.2M—−$5K$7K$1.4M−$1.2M
Q3 FY25−$1.0M−$47K−$5K—$1.1M−$1.1M

NutriBand: income statement and cash flow

NutriBand, Q2 FY27: revenue $438K (-30% year over year), operating margin -203.6%. The chart follows the revenue to costs, profit and cash.

NutriBand: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.